Guardian Pharmacy Services, Inc.
GRDN
$34.91
-$0.74-2.08%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 336.60M | 397.62M | 377.43M | 344.33M | 329.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 336.60M | 397.62M | 377.43M | 344.33M | 329.31M |
| Cost of Revenue | 260.29M | 312.11M | 302.71M | 276.19M | 264.96M |
| Gross Profit | 76.31M | 85.50M | 74.72M | 68.15M | 64.35M |
| SG&A Expenses | 55.43M | 50.14M | 57.82M | 53.07M | 51.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 315.72M | 362.25M | 360.53M | 329.26M | 316.01M |
| Operating Income | 20.88M | 35.37M | 16.90M | 15.08M | 13.30M |
| Income Before Tax | 18.29M | 31.10M | 16.63M | 12.59M | 13.11M |
| Income Tax Expenses | 4.75M | 9.83M | 7.04M | 3.76M | 3.83M |
| Earnings from Continuing Operations | 13.54M | 21.27M | 9.59M | 8.83M | 9.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -249.00K | -342.00K | 225.00K | 203.00K | 175.00K |
| Net Income | 13.30M | 20.92M | 9.82M | 9.03M | 9.45M |
| EBIT | 20.88M | 35.37M | 16.90M | 15.08M | 13.30M |
| EBITDA | 26.85M | 41.11M | 22.74M | 20.57M | 18.57M |
| EPS Basic | 0.11 | 0.33 | 0.16 | 0.15 | 0.08 |
| Normalized Basic EPS | 0.10 | 0.35 | 0.18 | 0.16 | 0.07 |
| EPS Diluted | 0.10 | 0.33 | 0.15 | 0.14 | 0.08 |
| Normalized Diluted EPS | 0.10 | 0.35 | 0.17 | 0.15 | 0.07 |
| Average Basic Shares Outstanding | 126.64M | 63.32M | 62.12M | 62.05M | 124.09M |
| Average Diluted Shares Outstanding | 127.38M | 63.62M | 63.43M | 63.20M | 125.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |